Characteristics | Data |
---|---|
Age at baseline, years | 53.93 ± 9.20 |
Sex, male, % | 456 (79.17%) |
Duration between LT and SRL initiation, months | 15.70 ± 33.5 |
eGFR at baseline, ml/min/1.73 m2 | 78.60 ± 42.94 |
SCr at baseline, mg/dL | 1.16 ± 0.72 |
Positive proteinuria at baseline (n = 535), n (%) | 75 (14.02%) |
Indications for liver transplantation, n (%) a | |
 Decompensated liver cirrhosis | |
  Hepatitis B | 317 (55.03%) |
  Hepatitis C | 162 (28.13%) |
  Alcoholic | 87 (15.10%) |
 HCC | 318 (55.21%) |
 Acute liver failure | 34 (5.9%) |
Baseline comorbidities, n (%) | |
 Congestive heart failure | 3 (0.52%) |
 Diabetes mellitus | 144 (25%) |
 Celebrovascular disease | 5 (0.87%) |
 Chronic pulmonary disease | 26 (4.52%) |
 Renal disease | 21 (3.65%) |
CNI use at baseline | 520 (90.28%) |
Plasma trough level of SRL, ng/mL | |
 <3 months, | 6.19 ± 3.52 |
 3-6 months | 6.26 ± 2.96 |
 6-12 months | 6.19 ± 2.88 |
Duration of follow-up, day, (n = 574) | 1075 ± 871.2 |